2014 Annual Meeting | Controversies in Neurology Plenary Session

Date Thursday 05/01/14

Time 05:30 PM - 07:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Plenary Session

Topic(s) Cerebrovascular Disease and Interventional Neurology, General Neurology, Multiple Sclerosis

CME Available No CME available

Event Timeline
05:30 PM - 06:00 PM		Does Preventing Relapses Protect Against Progressive MS? Helen Tremlett, PhD, BPharm, Maria Trojano
06:00 PM - 06:30 PM		Is Intervention for Asymptomatic AVM Useful? Robert Friedlander, J. P. Mohr, MD, FAAN
06:30 PM - 07:00 PM		Should Neurologists Prescribe Marijuana for Neurological Disorders? John C. Brust, MD, Barbara S. Koppel, MD, FAAN

Faculty Disclosures
Helen Tremlett, PhD, BPharm	Dr. Tremlett has nothing to disclose.
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Robert Friedlander	No disclosure on file
J. P. Mohr, MD, FAAN	The institution of Dr. Mohr has received research support from NINDS Grant R01 NS099268 NIH-NINDS .
John C. Brust, MD	No disclosure on file
Barbara S. Koppel, MD, FAAN	No disclosure on file